ES2072928T3 - Antigenos de celulas de islotes pancreaticos obtenidos por clonaje molecular. - Google Patents

Antigenos de celulas de islotes pancreaticos obtenidos por clonaje molecular.

Info

Publication number
ES2072928T3
ES2072928T3 ES90102179T ES90102179T ES2072928T3 ES 2072928 T3 ES2072928 T3 ES 2072928T3 ES 90102179 T ES90102179 T ES 90102179T ES 90102179 T ES90102179 T ES 90102179T ES 2072928 T3 ES2072928 T3 ES 2072928T3
Authority
ES
Spain
Prior art keywords
cells
antigens
proteins
molecular cloning
iddm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90102179T
Other languages
English (en)
Inventor
Daniel Rabin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Bayer Corp
Original Assignee
Bayer AG
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG
Application granted granted Critical
Publication of ES2072928T3 publication Critical patent/ES2072928T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

ANTIGENOS DE CELULAS DE ISLOTES DE LANG. PANCREATICOS (ICA) QUE SE ASOCIAN CON ANTICUERPOS ENCONTRADOS EN EL SUERO DE PACIENTES AFECTADOS DE DIABETES (IDDM) DEPENDIENTE DE INSULINA (TIPO I). LAS PROTEINAS ICA SE EXPRESAN MEDIANTE VEHICULOS DE CLONES RECOMBINADOS COMPRENDIENDO INSERCIONES AISLADAS DE DNA DE CELULAS DE ISLOTES DE L. SECUENCIAS COMPLETAS DE PROTEINAS ICA NATIVAS, O PROTEINAS, O FRAGMENTOS DE PEPTIDAS DE ELLAS, SE PUEDEN USAR EN EL DIAGNOSTICO DE LA IDDM, Y EN DETECCION O BLOQUEO DE INMUNOGLOBULINA HUMANA, CELULAS T, O CELULAS B INCLUIDAS EN IDDM.
ES90102179T 1989-02-17 1990-02-03 Antigenos de celulas de islotes pancreaticos obtenidos por clonaje molecular. Expired - Lifetime ES2072928T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31254389A 1989-02-17 1989-02-17
US44170389A 1989-12-04 1989-12-04

Publications (1)

Publication Number Publication Date
ES2072928T3 true ES2072928T3 (es) 1995-08-01

Family

ID=26978437

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90102179T Expired - Lifetime ES2072928T3 (es) 1989-02-17 1990-02-03 Antigenos de celulas de islotes pancreaticos obtenidos por clonaje molecular.

Country Status (14)

Country Link
EP (1) EP0383129B1 (es)
JP (1) JP2858467B2 (es)
AT (1) ATE122394T1 (es)
AU (1) AU626636B2 (es)
CA (1) CA2010275C (es)
DE (1) DE69019190T2 (es)
DK (1) DK0383129T3 (es)
ES (1) ES2072928T3 (es)
FI (1) FI103730B1 (es)
GR (1) GR3017019T3 (es)
IE (1) IE66997B1 (es)
IL (1) IL93397A (es)
NO (1) NO306996B1 (es)
PT (1) PT93166B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5645998A (en) 1988-12-13 1997-07-08 University Of Florida Research Foundation Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
US6001360A (en) * 1988-12-13 1999-12-14 University Of Florida Method and compositions for early detection and treatment of insulin dependent diabetes mellitus
JPH02200700A (ja) * 1989-01-30 1990-08-08 Shionogi & Co Ltd 新規ｒｅｇ蛋白質
US5175085A (en) * 1990-02-20 1992-12-29 Board Of Regents, The University Of Texas System Methods and compositions for diagnosing autoimmune insulin dependent diabetes mellitus
US5744327A (en) * 1990-02-20 1998-04-28 Board Of Regents, The University Of Texas System Methods for producing insulin in response to non-glucose secretagogues
US5427940A (en) * 1991-06-03 1995-06-27 Board Of Regents, The University Of Texas System Engineered cells producing insulin in response to glucose
WO1992004632A1 (en) 1990-09-07 1992-03-19 The Regents Of The University Of California Methods for the diagnosis and treatment of diabetes
US5674978A (en) * 1990-09-21 1997-10-07 The Regents Of The University Of California Peptides derived from glutamic acid decarboxylase
US5998366A (en) * 1990-09-21 1999-12-07 The Regents Of The University Of California Method for ameliorating glutamic acid decarboxylase associated autoimmune disorders
US6682906B1 (en) 1990-09-21 2004-01-27 The Regents Of The University Of California Cloned glutamic acid decarboxylase
WO1992006105A1 (en) * 1990-10-02 1992-04-16 Trigen Incorporated Antibodies and methods for diagnosis and treatment of diabetes
JPH06508030A (ja) * 1991-05-15 1994-09-14 ザイモジェネティクス，インコーポレイティド ヒトすい島グルタミン酸デカルボキシラーゼ自己抗原のクローニング及び発現
US5792656A (en) * 1991-06-03 1998-08-11 Board Of Regents, The University Of Texas System Methods of preparing genetically engineered cells that produce insulin in response to glucose
WO1993016725A1 (en) * 1992-02-27 1993-09-02 The Board Of Trustees Of The Leland Stanford Junior University Early antigen for autoimmune diabetes
US5200318A (en) * 1992-05-13 1993-04-06 Miles Inc. Diagnosis of IDDM with a panel of immunoreagents
WO1996038479A1 (fr) * 1995-05-30 1996-12-05 Fujisawa Pharmaceutical Co., Ltd. Procede de diagnostic du diabete sucre insulino-dependant et kit de diagnostic
AU1989097A (en) 1996-03-06 1997-09-22 University Of Washington Diabetes mellitus 37 kd autoantigen protein-tyrosine phosphatase
AU7159898A (en) * 1997-04-25 1998-11-24 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
CN110244051A (zh) * 2019-07-05 2019-09-17 许昌学院 一种用于糖尿病的多组分标记免疫检测系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE53862T1 (de) * 1982-01-22 1990-06-15 Cetus Corp Verfahren zur charakterisierung von hla und die darin benutzten cdns-testmittel.
IL69686A (en) * 1983-09-11 1988-03-31 Yeda Res & Dev Compositions containing cell membrane proteins and process for their preparation
WO1986007464A1 (en) * 1985-06-14 1986-12-18 Genetic Systems Corporation Methods for identifying alleles associated with increased risk of diabetes
CA1327162C (en) * 1987-04-09 1994-02-22 Board Of Trustees Of The Leland Stanford Junior University (The) Method for prophylactically treating an individual for an autoimmune disease
EP0359783B2 (en) * 1987-06-24 2002-04-17 Autoimmune, Inc. Treatment of autoimmune diseases by oral administration of autoantigens

Also Published As

Publication number Publication date
ATE122394T1 (de) 1995-05-15
FI103730B (fi) 1999-08-31
AU4988390A (en) 1990-08-23
NO900474L (no) 1990-08-20
EP0383129A2 (en) 1990-08-22
EP0383129A3 (en) 1991-07-31
NO900474D0 (no) 1990-02-01
IE66997B1 (en) 1996-02-21
DE69019190T2 (de) 1995-09-14
JPH0347133A (ja) 1991-02-28
PT93166A (pt) 1990-08-31
DE69019190D1 (de) 1995-06-14
DK0383129T3 (da) 1995-10-09
PT93166B (pt) 1997-11-28
JP2858467B2 (ja) 1999-02-17
FI900759A0 (fi) 1990-02-15
CA2010275C (en) 2000-08-29
IL93397A0 (en) 1990-11-29
GR3017019T3 (en) 1995-11-30
IL93397A (en) 1997-06-10
CA2010275A1 (en) 1990-08-17
IE900589L (en) 1990-08-17
FI103730B1 (fi) 1999-08-31
NO306996B1 (no) 2000-01-24
EP0383129B1 (en) 1995-05-10
AU626636B2 (en) 1992-08-06

Similar Documents

Publication Publication Date Title
ES2072928T3 (es) Antigenos de celulas de islotes pancreaticos obtenidos por clonaje molecular.
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
AU5417079A (en) Recombinant dna molecules
ES2165851T3 (es) Proteinas multivalentes que se unen a antigenos.
ATE232237T1 (de) Herstellung von funktionellen, menschlichen urokinaseproteinen
ATE87655T1 (de) Markierer der t-zelle aktivierung.
ATE106454T1 (de) Kennzeichnung und nachweis von mit autoimmunkrankheiten assoziierten sequenzen.
ES2085993T3 (es) Proteina asociada a la pancreatitis aguda, medios para el diagnostico de la pancreatitis aguda.
PT97574A (pt) Processo de obtencao de proteinas de superficie cd44 variaveis, sequencias do dna que as codificam, anticorpos destas proteinas, bem como a sua utilizacao no diagnostico e na terapia
ATE238065T1 (de) Peptide zur verwendung in impfung und anregung von antikörperbildung gegen menschliches immunschwäche virus
RU94046414A (ru) Моноклональные антитела к гликопротеину р, их получение и применение, продуцирующие их клетки, иммунологический диагностический набор на их основе, терапевтический состав
AU612683B2 (en) Synthetic peptides, antibodies directed against them, and the use thereof
DE69333952D1 (de) Klonering von dem gen für das t gondii protein gp 28.5 peptidfragmente aus diesem protein und ihre verwendungen.
EP0293827A3 (en) Assay for leishmaniasis
DE69840628D1 (de) Nicht-anaphylaktische allergenarten und ihre verwendung
MX9102647A (es) Nueva proteina capaz de inducir una respuesta inmunoprotectora contra la infeccion causada por toxoplasma gondii y para clonar y expresar un gen que codifica a la proteina.
DE3877136D1 (de) Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung.
FI870501L (fi) Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut
DE68926813D1 (de) Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide
ES2155436T3 (es) Proteinas recombinantes con la reactividad inmunologica del antigeno e del virus de la hepatitis b (hbeag), procedimiento para su preparacion y su utilizacion en analisis inmunologicos y en vacunas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 383129

Country of ref document: ES